A combined preclinical therapy of cannabinoids and temozolomide against glioma
- PMID: 21220494
- DOI: 10.1158/1535-7163.MCT-10-0688
A combined preclinical therapy of cannabinoids and temozolomide against glioma
Abstract
Glioblastoma multiforme (GBM) is highly resistant to current anticancer treatments, which makes it crucial to find new therapeutic strategies aimed at improving the poor prognosis of patients suffering from this disease. Δ(9)-Tetrahydrocannabinol (THC), the major active ingredient of marijuana, and other cannabinoid receptor agonists inhibit tumor growth in animal models of cancer, including glioma, an effect that relies, at least in part, on the stimulation of autophagy-mediated apoptosis in tumor cells. Here, we show that the combined administration of THC and temozolomide (TMZ; the benchmark agent for the management of GBM) exerts a strong antitumoral action in glioma xenografts, an effect that is also observed in tumors that are resistant to TMZ treatment. Combined administration of THC and TMZ enhanced autophagy, whereas pharmacologic or genetic inhibition of this process prevented TMZ + THC-induced cell death, supporting that activation of autophagy plays a crucial role on the mechanism of action of this drug combination. Administration of submaximal doses of THC and cannabidiol (CBD; another plant-derived cannabinoid that also induces glioma cell death through a mechanism of action different from that of THC) remarkably reduces the growth of glioma xenografts. Moreover, treatment with TMZ and submaximal doses of THC and CBD produced a strong antitumoral action in both TMZ-sensitive and TMZ-resistant tumors. Altogether, our findings support that the combined administration of TMZ and cannabinoids could be therapeutically exploited for the management of GBM.
©2010 AACR.
Similar articles
-
Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.Biochem Pharmacol. 2018 Nov;157:266-274. doi: 10.1016/j.bcp.2018.09.007. Epub 2018 Sep 7. Biochem Pharmacol. 2018. PMID: 30195736
-
Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma.Biochem Pharmacol. 2018 Nov;157:275-284. doi: 10.1016/j.bcp.2018.08.023. Epub 2018 Aug 18. Biochem Pharmacol. 2018. PMID: 30125556
-
Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition.J Neurooncol. 2017 May;132(3):393-400. doi: 10.1007/s11060-017-2387-y. Epub 2017 Mar 14. J Neurooncol. 2017. PMID: 28293765
-
Targeting autophagy to sensitive glioma to temozolomide treatment.J Exp Clin Cancer Res. 2016 Feb 2;35:23. doi: 10.1186/s13046-016-0303-5. J Exp Clin Cancer Res. 2016. PMID: 26830677 Free PMC article. Review.
-
An Interplay between Senescence, Apoptosis and Autophagy in Glioblastoma Multiforme-Role in Pathogenesis and Therapeutic Perspective.Int J Mol Sci. 2018 Mar 17;19(3):889. doi: 10.3390/ijms19030889. Int J Mol Sci. 2018. PMID: 29562589 Free PMC article. Review.
Cited by
-
Anti-proliferative and apoptotic effect of cannabinoids on human pancreatic ductal adenocarcinoma xenograft in BALB/c nude mice model.Sci Rep. 2024 Mar 18;14(1):6515. doi: 10.1038/s41598-024-55307-y. Sci Rep. 2024. PMID: 38499634 Free PMC article.
-
Cannabinoids in the treatment of glioblastoma.Pharmacol Rep. 2024 Apr;76(2):223-234. doi: 10.1007/s43440-024-00580-x. Epub 2024 Mar 8. Pharmacol Rep. 2024. PMID: 38457018 Review.
-
Icariin exerts anti-tumor activity by inducing autophagy via AMPK/mTOR/ULK1 pathway in triple-negative breast cancer.Cancer Cell Int. 2024 Feb 14;24(1):74. doi: 10.1186/s12935-024-03266-9. Cancer Cell Int. 2024. PMID: 38355608 Free PMC article.
-
Targeting the Endocannabinoid System Present in the Glioblastoma Tumour Microenvironment as a Potential Anti-Cancer Strategy.Int J Mol Sci. 2024 Jan 23;25(3):1371. doi: 10.3390/ijms25031371. Int J Mol Sci. 2024. PMID: 38338649 Free PMC article. Review.
-
Emerging Lipid Targets in Glioblastoma.Cancers (Basel). 2024 Jan 17;16(2):397. doi: 10.3390/cancers16020397. Cancers (Basel). 2024. PMID: 38254886 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
